, , ,

<<


 >>  ()
Pages:     | 1 |   ...   | 3 | 4 ||

1 .. , .. , .. (.), .. , .. , .. ...

-- [ 5 ] --

247. .. : . . . .

. : / .. . ., 1986.

248. .. / . . , . . . : , 1999.

249. .. 䳿 / .. // . 2004. . 8, 1. . 714.

250. .. : . ./ .. . .: , 1986. 372 .

251. .., .. / .. // . 1937. .4, 1. . 7578.

252. .. / .. , .. // . 1937. .4, 1. . 7982.

253. /.. , .. , .. , .. // . 3 . .: , 1988. . 27. . 177.

254. .. / .. , .. . ., 2005. 596 .

255. .. / . . , .. , . . . // . 1987. 1.

. 21-30.

256. .. / .. . .: .

, 2001. 1024 .

257. .. : / .. . .: , 1961. 261 .

258. .. / .. . .: , 1954. 280 .

259. .. / .. , .. , .. // . 2001. 5. . 2224.

260. .. / .. , .. , .. // . 1997.

3. . 17-19.

261. .. . , / .. . .: , 1960. 551 .

262. .. / .. . .: , 1965. 331 .

263. .. / .. , .. , .. //VI . , 1998. .263.

264. .. : . . . . : 14.00.16/ .. .

, 1981. 131 .

265. .. / .. // . 1993. . 113, 5. . 617625.

266. . : . . / . . .: , 1988.

280 .

267. , / .. , .. , .. . // . 2000. .3. .20-24.

268. .. / .. , .. // III . , 2002. . 451-452.

269. Aberrated levels of cerebrospinal fluid chemokines in 164 GuillainBarre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy / R. Press, M. Pashenkov, J.P. Jin, H. Link // Journal of Clinical Immunology. 2003. Vol. 23, 4. . 259267.

270. Abraham A.D. 3Htestosterone distribution and binding in rat thymus cells in vivo / A.D. Abraham, G. Bug // Mol Cell Biochem. 1976. Vol. 13. P. 15763.

271. Adguhr E. Ube rein zentrales Sinnesorgan bei den vertebraten / E.Adguhr // Z. Anat. Entwgesch. 1922. Vol. 66. P. 223360.

272. Adinolfi A. Alfafetoprotein during development and in desease / . Adinolfi, . Adinolfi, M.H.Lessof // J. Med. Genet. 1975.

Vol.12. P. 138.

273. Akefeldt A. Cerebrospinal fluid neuropeptide Y in Prader Willi syndrome / . Akefeldt, R. Ekman, J.Mansson // Developmental Medicine & Child Neurology. 2001. Vol. 43, 4. . 286287.

274. Alphamelanocytestimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease / L. Rainero, J.A. Kaye, C. May et al. // Arch. neurol. 1988. Vol. 45, 11. P. 12241227.

275. Analysis of tryptophan and tyrosine in cerebrospinal fluid by capillary electrophoresis and ''ball lens'' UVpulsed laserinduced fluorescence detection / C. Bayle, N. Siri, V. Poinsot et al. // Journal of Chromatography A. 2003. Vol. 1013, 12. . 123130.

276. Angelow S. Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells / S. Angelow, . Haselbach, .- J.Galla // Brain Research.

2003. Vol. 988, 12. . 105113.

277. Armstrong C. S. Uptake of circulating insulinlike growth factorI into the cerebrospinal fluid of normal and diabetic rats and normalization of IGFII mRNA content in diabetic rat brain / . S.

Armstrong, L. Wuarin, D.N. Ishii // J. Neurosci. Res. 2000. Vol. 59, 5. P. 649660.

278. Arrenbrecht S. Specific binding of growth hormone to thymocyies / S. Arrenbrecht // Nature. 1974. Vol. 252. P. 255257.

279. Assies J. Protein hormones in the cerebrospinal fluid:

Evidence for retrograde transport from the pituitary to the brain in man / J.Assies, . Schellekens, J.L. Touber // Clin. Endocr. 1978. Vol. 8, 2. P. 487491.

280. Baehr C. Choroid plexus epithelial monolayers a cell culture model from porcine brain / C. Baehr, V. Reichel, G. Fricker // Cerebrospinal Fluid Research. 2006. Vol. 3, 13. P. 114.

281. Banks W.A. Selective, physiological transport of insulin across the bloodbrain barrier: novel demonstration by speciesspecic radioimmunoassays / W.A. Banks, J.B. Jaspan, A.J. Kastin // Peptides. 1997. Vol. 18, 8. P. 12571262.

282. Becher Burchard. Brainimmune connection: Immuno regulatory properties of CNSresident cells / Becher Burchard, Prat Alexandre, . Antel Jack // Glia. 2000. Vol. 29, 4. P. 293304.

283. Bechter K. Cerebrospinal fluid filtration as experimental treatment in a case of Borna disease vims-encephalitis-related schizophrenia. 4th Symposium on the neurovirology and neuroimmunology of shizophrenia and bipolar disorder 57 november Bethesda. Maryland, 1998. .123.

284. Berciano J. Cerebrospinal fluid filtration for treating Guillain Barre syndrome is there any pathological background / Berciano J. // Anaesthesia. 2000. Vol. 55, 4. . 408.

285. Bleier R. The relations of ependima to neurons and capillaries in the hypothalamus: a Golgicox study / R. Bleier // J. Comp. Neurol. 1971. Vol. 142, 4. P. 439463.

286. Bloodbrain barrier transport of cationised immunoglobulin G:

enchanced delivery compared to native protein / Triguero D., Buciac J.B., Yang J., Pardridge W.M. // Proc. Nat. Acad. Sci. USA 1989. Vol. 86, 12. P. 47614765.

287. Bloodbrain, bloodcerebrospinal fluid and cerebrospinal fluidbrain barriers in a marsupial (macropus eugenii) during development / K. M. Dziegielewska, L. A. Hinds, K. Mollgard et al. // Journal of Physiology. 1988. Vol. 403. P.367388.

288. Bouchaud C. Serotoninergic innervations of ependimal cells in the rat subcomissural organ. A fluorescence electron microscopic and radioautographic study / . Bouchaud, . Arfuison // Biol. Cell. 1977.

Vol. 30, 1. P. 6164.

166 289. Bradbury M.W.B. Transport of iron in the bloodbrain cerebrospinal fluid system / M.W.B. Bradbury // Journal of Neurochemistry. 1997. Vol. 69. P. 443454.

290. Brainderived neurotrophic factor in cerebrospinal fluid of patients with chronic daily headache: relationship with nerve growth factor and glutamate levels / P. Sarchielli, A. Alberti, B. Gallai et al. // The Journal of Headache and Pain. 2002. Vol. 3. . 129135.

291. Bulat M. Biochemical communication of the brain and cerebrospinal fluid / . Bulat // Periodicum Biologorum. 1980. Vol.82. P. 251 292. Cake M.H., Litwack G. The glucocorticoid receptors / ..

Cake, Litwack G. // Biochemical Actions of Hormones. 1975. Vol 3.

. 90.

293. Caulaert van C. Sur la presence de lhormone prehypophysaire excitesecretrice de la thyroide dans le sang et le liquid cephalorachidien et sur la repartition dans ces milieux / . Caulaert van, . Aron, Stahl J. // Comp. Rend. Soc. Biol. 1931. Vol. 106. P.

607609.

294. Cerebrospinal fluid pheresis in Guillain-Barre syndrome / Wollinsky K.H., Hulser P.J., Westarp M.E. et al. //Med Hypoth. 1992.

Vol. 38. . 155-165.

295. Cerebrospinal fluid adrenomedullin levels in patients with preeclampsia / O. Celik, S. Hascalik, M. Yurekli, Y. Turkoz // Acta Obstetricia Et Gynecologica Scandinavica. 2003. Vol. 82, 6. .

578579.

296. Cerebrospinal uid affects phenotype and functions of myeloid dendritic cells / M. Pashenkov, M. Soderstrom, Y.M. Huang et al. // Clin Exp Immunol. 2002. Vol. 128. P. 379387.

297. Cerebrospinal fluid and plasma concentrations of POMCrelated peptides in multiple sclerosis / L. Pinessi, I. Rainero, . de Gennaro et al. // Ann N Y Acad Sci. 1992. Vol. 650, 7. P. 351354.

298. Cerebrospinal fluid and plasma concentrations of SRIH, beta endorphin, CRH, NPY and GHRH in obese and normal weight subjects / A. Brunani, C. Invitti, A. Dubini et al. // J. Obes. Relat. Metab. Disord. 1995. Vol. 19, 1. P. 1721.

299. Cerebrospinal fluid and plasma leptin measurements:

covariability with dopamine and cortisol in fasting humans / M.M.

Hagan, P.J. Havel, R.J. Seeley et al. // J. Clin. Endocrinol. Metab. 1999. Vol. 84, 10. P. 35793585.

300. Cerebrospinal fluid and serum protein levels of tumor necrosis factoralpha (TNF), interleukin6 (IL6) and soluble interleukin receptor (sIL6R gp80) in multiply sclerosis patient / S.A. Vladic, G.

Horvat, S. Vukadin et al. // Cytokine. 2002. Vol. 20, 2. . 8689.

301. Cerebrospinal fluid concentrations of corticotropinreleasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment / I. Heuser, G.

Bissette, M. Dettling et al. // Depress Anxiety. 1998. Vol. 8, 2. P. 7179.

302. Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions / J.D. Coplan, R.C. Trost, M.J. Owens et al. // Arch. Gen. Psychiatry. 1998. Vol. 55, 5. P. 473477.

303. Cerebrospinal fluid cytokines in AIDS dementia complex /.

Perella, Carrieri P.B., Guarnaccia D., . Soscia // J. Neurol. 1992. Vol. 239. P. 387388.

304. Cerebrospinal fluid filtration and immunoglobulins in multifocal motor neuropathy./ Finsterer J., Schwerer ., Bittner R.E., Mamoli B. // Clin Neuropathol. 1999. Vol 18, 1. . 31-36.

305. Cerebrospinal fluid filtration in a case of schizophrenia related to subclinical Borna disease virus encephalitis / Bechter ., Herzog S., Schreiner V. et al. // Psychiatry, Psychoneuroimmunology, and Viruses / Ed. N. Muller. Wien: Springer, 1999. . 19-35.

306. Cerebrospinal fluid filtration in multiple sclerosis in patients as an experimental therapeutic approach / Haas J., Sailer M., Diizel E. et al.

//J Neuroimmunol. Suppl 1995. Vol. 1. .37.

307. Cerebrospinal fluid insulinlike growth factor1, insulin growth factor binding protein2 or nitric oxide are not increased in MS or ALST / . Pirttila, S. Vanhatalo, U. Turpeinen, R. Riikonen // Acta Neurologica Scandinavica. 2004. Vol. 109, 5. . 337341.

168 308. Cerebrospinal fluid levels of alphatocopherol in amyotrophic lateral sclerosis / F. De Bustos, F.J. JimenezJimenez, J.A. Molina et al.

// J. Neural. Transm. 1998. Vol. 105, 67. P. 703708.

309. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis / T.

Ichiyama, H. Shoji, M. Kato et al. // European Journal of Pediatrics. 2002. Vol. 161, 3. . 133137.

310. Cerebrospinal fluid levels of insulin in patients with Alzheimer's disease / J.A. Molina, F.J. JimenezJimenez, C. Vargas et al. // Acta Neurologica Scandinavica. 2002. Vol. 106, 6. . 347350.

311. Cerebrospinal fluid levels of neuropeptides, cortisol, and amino acids in patients with epilepsy / O. Devinsky, S. Emoto, N.S.

Nadi, W.H. Theodore // Epilepsia. 1993. Vol. 34, 2. P. 255261.

312. Cerebrospinal fluid levels of oxytocin in PraderWilli syndrome: a preliminary report / A. Martin, M. State, G.M. Anderson et al. // Biol. Psychiatry. 1998. Vol. 44, 12. P. 13491352.

313. Cerebrospinal fluid levels of thiamine in patients with Alzheimer's disease / J.A. Molina, F.J. JimenezJimenez, A. Hernanz et al. // Journal of Neural Transmission. 2002. Vol. 109, 78. .

10351044.

314. Cerebrospinal fluid levels of thiamine in patients with Parkinson's disease / F.J. JimenezJimenez, J.A. Molina, A. Hernanz et al. // Neurosci Lett. 1999. Vol. 271, 1. P. 3336.

315. Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis / C.A. Roca, T.P. Su, S. Elpern et al. // Biol.

Psychiatry. 1999. Vol. 46, 4. P. 551556.

316. Cerebrospinal fluid supports viability and proliferation of cortical cells in vitro, mirroring in vivo development / J.A. Miyan, M.

Zendah, F. Mashayekhi et al.// Cerebrospinal Fluid Research. 2006. Vol. 3, 2. P. 17.

317. Cerebrospinal fluid-filtration reduces TNF-alpha in bacterial meningitis CSF / Pfausler ., Grubwieser G., Bosch S. et al. // Eur J Neurol. 1995. Vol. 2. .570572.

318. Changes in plasma LRH during the normal menstrual cycle in women / A. Miyake, J. Kawamurra, T. Aono, K. Kurachi // Acta endocr.

1980. Vol. 93, 3. P. 257263.

319. Changes with aging of steroidal levels in the cerebrospinal fluid of women / K. Murakami, . Nakagawa, M. Shozu et al. // Maturities. 1999. Vol. 33, 1. P. 7180.

320. Cholinergic augmentation of lymphocytemediated cytotoxicity. A study of the cholinergic receptor of cytotoxic T lymphocytes / T.B. Strom, A.J. Sytkowkski, C.B. Carpenter et al. // Proc Natl Acad Sci USA. 1974. Vol. 71. P. 13301333.

321. Chrousos G.P. The hypothalamicpituitaryadrenal axis and immunemediated inflammation / Chrousos G.P. // N Engl J Med. 1995. Vol. 332. P. 13511362.

322. Circadian rhythmicity of vasopressin levels in the cerebrospinal fluid of suprachiasmatic nucleuslesioned and grafted rats / K.E. Van Esseveldt, B.A. van der Geest, H. Duindam et al. // J.

Biol. Rhythms. 1999. Vol. 14, 1. P. 2836.

323. Clemens J.A. Identification of prolactin in cerebrospinal fluid / Clemens J.A., . Sawyer // Exptl Brain Res. 1974. Vol. 21, 4. P.

399402.

324. CNS immune privilege: hiding in plain sight / M.J. Carson, J..M. Doose, B. Melchior et al. // Immunol Rev. 2006. Vol. 213. P.

4865.

325. Concentrations of serotonin and its related substances in the cerebrospinal fluid in patients with Alzheimer type dementia / H. Tohgi, . Abe, S. Takahashi et al. // Neurosci Lett. 1992. Vol. 141, 1. P. 912.

326. Concept and therapeutic effiency of CSF fltration in acute cases of Guillain-Barre syndrome / Wollinsky K.H., Hulser P.-J., Brinkmeier H. et al. // Symposium CSF filtration a new concept for the treatment of neurological diseases with autoimmune pathogenesis.

Magdeburg, 1994. . 142-144.

327. Continuous filtration of cerebrospinal fluid (CSF-Filtration) in fulminant bacterial meningitis / Kalischewski P., D. Schneider, Khn H.-J. et al. // A New adjuvant Therapeutic Strategy In Anesthesia, Pain, Intensive Care and Emergency Medicine, A. Gullo (eds). Trieste, Foliazza Editore, 1996. . 627-638.

328. Correlation between concentrations of calcitonin and parathyroid hormone in cerebrospinal fluid of man / S. Balabanov, V.

170 Tollner, H. Richter et al. // Acta endocrinol. 1983. Vol. 103, 25. P. 133135.

329. Corticotropinreleasing factor (CRF) and interleukin1 (ILl) receptors in the brainpituitaryimmune axis / E.B. De Souza, E.L.

Webster, D.E. Grigoriadis et al. // Psychopharmacol Bull. 1989. Vol.

25. P. 299305.

330. CSF insulinlike growth factor1 in infantile neuronal ceroid lipofuscinosis / R. Riikonen, S.L. Vanhanen, J. Tynela et al. // Neurology. 2000. Vol. 54, 9. P. 18281832.

331. CSF monoamines, age and impulsivity in wild grivet monkeys (Cercopithecus aethiops) / L.A. Fairbanks, M.B. Fontenot, J.E.

PhillipsConroy et al. // Brain Behav Evol. 1999. Vol. 53, 5 6. P. 305312.

332. Cushing H. Concerning the secretion of the infundibular lobe of the pituitary body and its presence in the cerebrospinal fluid / .

Cushing, . Goetsch // Am. J. Physiol. 1910. Vol. 27. P. 6086.

333. Dachel R. CSF filtration in the hronic inflammatory demyelinating polyneuropathy / Dachel R., Knietsch A. //Symposium CSF filtration a new concept for the treatment of neurological diseases with autoimmune pathogenesis. Magdeburg, 1994.

334. Davidsson P. Peptide mapping of proteins in cerebrospinal uid utilizing a rapid preparative twodimensional electrophoretic procedure and matrixassisted laser desorption/ionization mass spectrometry / P. Davidsson, C.L. Nilsson // Biochimica et Biophysica Acta. 1999. Vol. 1473. P. 391399.

335. Davson H. The bloodbrain barrier / H. Davson // J. Physiol. 1976. Vol. 255. P. 128.

336. Dean A. Seehusen. Cerebrospinal fluid analisis / Dean A.

Seehusen, Mark M. Reeves, Demitri A. Fomin // Am. Fam. Physician. 2003. Vol. 68. P. 11031108.

337. Deane R. Brain capillary endothelium and choroid plexus epithelium regulate transport of transferrinbound and free iron into the rat brain / R. Deane, W. Zheng, B.V. Zlokovic // Journal of Neurochemistry. 2004. Vol. 88. P. 813820.

338. Decreased cerebrospinal fluid levels of bendorphin and ACTH in children with infantile spasms / S. Nagamitsu, T. Matsuishi, Y.

Yamashita et al. // Journal of Neural Transmission. 2001. Vol. 108, 3. P. 363371.

339. Decreased plasma and cerebrospinal fluid content of neuroactive steroids in Parkinson's disease / F. Michele, P. Longone, E. Romeo et al. // Neurological Sciences. 2003. Vol. 24, 3. . 172173.

340. Desiderio D. M. Mass spectrometric analysis of neuropeptidergic systems in the human pituitary and cerebrospinal fluid / D.. Desiderio // J. Chromatogr Biomed Sci Appl. 1999. Vol.

731, 1. P. 322.

341. Determination of free and total (free plus proteinbound) melatonin in plasma and cerebrospinal fluid by highperformance liquid chromatography with fluorescence detection / V. Rizzo, C. Porta, M.

Moroni et al. // Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2002. Vol. 774, 1. . 1724.

342. Differences in immune cell invasion into the cerebrospinal fluid and brain parenchyma during cerebral infusion of interleukin1 / B. Schoning, P. Elepfandt, N. Daberkow et al. // Neurol Sci. 2002. Vol. 23. P. 211218.

343. Direct isolation of human central nervous system stem cells / N. Uchida, D.W. Buck, D. He et al. // PNAS. 2000. Vol. 97, 26. P.14720 14725.

344. Dixon W. Pituitary secretion / W.Dixon // J. Physiol. 1923. Vol. 57. P. 129138.

345. Does neonatal cerebrospinal fluid absorption occur via arachnoid projections or extracranial lymphatics? / . Papaiconomou, R.

BozanovicSosic, . Zakharov, . Johnston // Amer. J. Physiol. 2002. Vol. 283, 4, . 2. . R869R876.

346. Doseeffects of recombinant human interleukin6 on pituitary hormone secretion and energy expenditure / . Tsigos, D.A.

Papanicolaou, R. Defensor et al. // Neuroendocrinology. 1997. Vol.

66. P. 5462.

347. Dreder C.D. TNF immunoreactive innervation in the mouse brain / C.D. Dreder, ..Saper // Soc. Neirosci Abstr. 1988. Vol.

144. P. 1280.

348. Duque M. C. Immunophenotyping of blood and cerebrospinal fluid leukocytes in dogs / M. C. Duque. 2001. 55 p.

172 349. Dynamic properties of lymphatic pathways for the absorption of cerebrospinal fluid / T. Brinker, W. Ledemann, D. Berens von Rautenfeld et al. // Acta Neuropathol. 1997. Vol 94. P. 493498.

350. Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels / JiangNing Zhou, RongYu Liu, Wouter Kamphorst et al. // Journal of Pineal Research. 2003. Vol. 35, 2. . 125130.

351. Effects of physical activity and acupuncture on calcitonin generelated peptide immunoreactivity in different parts of the rat brain and in cerebrospinal fluid, serum and urine / Y. Wyon, M. Hammar, E.

Theodorsson, T. Lundeberg // Acta Physiol Scand. 1998. Vol. 162, 4. P. 517522.

352. Egashira . HTR2C Cys23Ser polymorphism in relation to CSF monoamine metabolite concentrations and DSMIIIR psychiatric diagnoses / . Egashira, F. Takayama, Y.Yamanaka // Biol. Psychiatry.

1999. Vol. 46, 6. P. 821826.

353. Egashira . Changes in monoamine metabolites concentrations in rat cerebrospinal fluid after acute and longterm administration of a selective serotonin reuptake inhibitor, trazodone / . Egashira, Takayama F., Yamanaka Y. // Pharmacol Res. 1999. Vol. 40, 6. P. 503508.

354. Elevated CSF prostaglandin E2 levels in patients with probable AD / T.J. Montine, K.R. Sidell, B.C. Crews et al. // Neurology.

1999. Vol. 55, 7. P. 14951498.

355. Elevated interleukin6 levels in cerebrospinal fluid of vascular dementia patients / K. WadaIsoe, Y. Wakutani, K. Urakami, K.

Nakashima // Acta Neurologica Scandinavica. 2004. Vol. 110, 2.

. 124127.

356. Engelborghs S. Amino acids and biogenic amines in cerebrospinal fluid of patients with parkinson's disease / S. Engelborghs, Marescau , .. De Deyn // Neurochemical Research. 2003. Vol.

28, 8. . 11451150.

357. Establishment and properties of neural stem cell clones:

plasticity in vitro and in vivo / A.L. Vescovi, E.Y. Snyder // Brain Pathol. 1999. Vol. 9, 3. P.569 598.

358. Etude dun liquide cephalo-rachidien artificiel / Lataste X., Vandendriessche M., Castel J.P., Cohadon F. //Neurochirurgie (Paris). 1980. Vol. 26, 3. . 201-220.

359. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, nonhuman primates and other mammalian species / M. Johnston, A. Zakharov, C. Papaiconomou et al.

// Cerebrospinal fluid research. 2004. Vol. 1, 2. P. 1 13.

360. Extraordinary changes in excitatory amino acid levels in cerebrospinal fluid of Influenzaassociated encephalopathy of children / H. Kawashima, T. Morishima, T. Togashi et al. // Neurochemical Research. 2004. Vol. 29, 8. . 15371540.

361. Fabian R. H. Intraneuronal Ig G in the central nervous system / R. . Fabian, G. Petroff // Neurol. 1987. Vol.37, 9. P. 17801784.

362. Fabian R. H. Uptake of antineuronal Ig M by CNS neurons:

comparison with antineuronal Ig G / R. . Fabian // Neurol. 1990. Vol.40, 5. P. 419422.

363. Filtration of cerebrospinal fluid for acute demyelinating neuropathy in systemic lupus erythematosus / Stahl H.-D., Kalischewski P., Orda C. et al. //Clin Rheanimatol. 2000. Vol. 19 . 61-63.

364. Filtration of cere-brospinal fluid in acute inflammatory demyelinating polyneuropathy (Guillain-Barre syndrome)/ Wollinsky K.H., Hulser P.J., Brinkmeier H. et al. // Ann Med Intern 1994. Vol.145. . 451-458.

365. Finsterer J. Cerebrospinal fluid filtration in amyotrophic lateral sclerosis / Finsterer J., Mamoli . // Eur J Neurol. 1999. Vol. 65. . 597-600.

366. Finsterer J. Liquorpheresis (CSF filtration) in familial amyotrophic lateral sclerosis. / Finsterer J., Mamoli .//Spinal Cord. 1999. Vol 37, 8. .592-594.

367. Fliedner T.M. The stem cell system of hematopoiesis:

physiological and pathophysiological concepts/ T.M. Fliedner, W.Nothdurft, W. Calvo //Verh Dtsch Ges Pathol. 1990.Vol. 74.P.118.

368. Friede R. L. A new approach for determining the volume of cerebral extracellular fluid and demonstration of its communication with CSF / R.L. Friede, Kuo Hao Hu // J. Physiol. 1971. Vol. 218. P. 477493.

174 369. Gerner M. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patient / . Gerner, Yamada T. // Brain res. 1982. Vol. 238, 1. P. 298302.

370. Gillette S. Changes in thymic estrogen receptor expression following orchidectomy / S. Gillette, R. Gillette // Cell Immunol. 1979. Vol. 42. P. 194196.

371. Gonadotropinreleasing hormone secretion into thirdventricle cerebrospinal fluid of cattle: correspondence with the tonic and surge release of luteinizing hormone and its tonic inhibition by suckling and neuropeptide Y / O.S. Gazal, L.S. Leshin, R.L. Stanko et al. // Biol.

Reprod. 1998. Vol. 59, 3. P. 676683.

372. Grimes M.A. Cerebrospinal fluid concentrations of tryptophan and 5hydroxyindoleacetic acid in Macaca mulatta: diurnal variations and response to chronic changes in dietary protein intake / .. Grimes, Cameron J.L., Fernstrom J.D. // Neurochem Res. 2000. Vol. 25, 3. P. 413422.

373. Guidelines on routine cerebrospinal uid analysis. Report from an EFNS task force / F. Deisenhammer, A. Bartos, R. Egg et al. // European Journal of Neurology. 2006. Vol. 13. P. 913922.

374. Hefco V. The modulator role of the hypothalamic paraventricular nucleus of immune responsiveness / Hefco V., Olariu V.

A., . Hevko // Brain Behav. Immunol. 2004. Vol. 18, 2. P.

158165.

375. Helderman J.H. Specific insulin binding site on T and B lymphocytes as a marker of cell activation / J.H. Helderman, T. Strom // Nature. 1978. Vol. 274. P. 6263.

376. Hepatocyte growth factor in cerebrospinal fluid in neurologic disease / Y. Tsuboi, K. Kakimoto, H. Akatsu et al. // Acta Neurologica Scandinavica. 2002. Vol. 106, 2. . 99103.

377. Hepatocyte growth factor levels in cerebrospinal fluid: a comparison between fcute bacterial and nonbacterial meningitis / F.

Nayeri, I. Nilsson, L. Hagberg et al. // J. Infect. Dis. 2000. Vol. 181, 6. P. 20922094.

378. Herring P. The histological appearances of the mammalian pituitary body / . Herring // Quart. J. Experim. Phisiol. - 1908. Vol. 1, 5 P. 121159.

379. Hiesland P. Mechanism of action: cyclosporin and prolactin mediated control of immunity / P. Hiesland, P. Mekler // Prog. Allergy.

1986. Vol. 38. P. 239246.

380. Hirai K. Cerebrospinal fluid somatostatin levels in febrile seizure and epilepsy in children / . Hirai, . Seki // Neuropeptides. 2000. Vol. 34, 1. P. 1824.

381. Hoff H. Untersuchungen uber die Becinflussung der Pituitrinsecretion durch Diuretica / . Hoff, . Wermer // Klin.

Wochenschr. 1927. 5. S. 25.

382. Holienberg M.D. Hormone receptors and membrane glycoproteins during in vitro transformation of lymphocytes / Holienberg M.D., . Cuatrecasa New York: Cold Spring Harbor Laboratory, 1974. .423434.

383. Hulser P.J. Liquorpheresis eliminates blocking factors from cerebrospinal fluid in polyradiculoneuritis (Guillain-Barre syndrome) / Hulser P.J., Wietholter H., Wollinsky K.H. // Eur Arch Psychiat Clin Neurosci. 1991. Vol. 241, 2. .69-72.

384. Human cerebrospinal fluid contains CD4+ memory T cells expressing gut or skinspecific trafficking determinants: relevance for immunotherapy / P. Kivisakk, B. Tucky, T. Wei et al. // BMC Immunology. 2006. Vol. 7, 14. P. 18.

385. Human chorionic gonadotrophin in CSF, not serum, predicts outcome in germinoma / . Inamura, S. Nishio, K. Ikezaki, M. Fukui // J. Neurol. Neurosurg. Psychiatry. 1999. Vol. 66, 5. P. 654657.

386. Identification of betaadrenoceptors during thymocyte ontogeny in mice / U. Singh, D.S. Millson, P.A. Smith et al. // Eur J lmmunol. 1979. Vol. 9. P. 3135.

387. IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test / V. Lejon, D. Legros, M. Richer et al. // Tropical Medicine & International Health. 2002. Vol. 7, 8. . 685692.

388. Ilzecka J. Brainderived neurotrophic factor is not altered in the serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients / Ilzecka J., Stelmasiak Z. // Neurological Sciences. 2002. Vol. 22, 6. . 473474.

389. In situ histochemical localization of type I interleukin 176 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse /E.T. Cunningham, E. Wada, D.B. Carter et al. // J. Neurosci. 1992. Vol.12. P. 11011114.

390. In vitro studies of immunoregulation by substance P and somatostatin /A. Stanisz, R. Scicchitano, D. Payan et al. // Ann N Y Acad Sci. 1987. Vol. 496. P. 217225.

391. Increased cerebrospinal fluid cAMP levels in Alzheimer's disease / M. Martinez, E. Fernandez, A. Frank et al. // Brain Res. 1999.

Vol. 846, 2. P. 265267.

392. Increased hepatocyte growth factor level in cerebrospinal fluid in Alzheimer's disease / Y. Tsuboi, K. Kakimoto, M. Nakajima et al. // Acta Neurologica Scandinavica. 2003. Vol. 107, 2. . 8186.

393. Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression / . Kirkergaard, Faber J., Hummer L., .

Rogowsci P. // Psychoneuroendocrinology. 1979. Vol. 4, 3. P.

227235.

394. Influence of CSF filtration on a new gliotoxic factor in cerebrospinal fluid from multiple sclerosis patients / . Dobransky, Amouri R., Wollinsky K.H. et al. // Neuropsychiatrie. 1995. Vol. 9. . 89-93.

395. Insulinlike growth factor binding proteins in cerebrospinal fluid during human development and aging / P. M. Arnold, J.Y. Ma, B.A. Citron, B.W. Festoff // Biochem. Biophys. Res. Commun. 1999.

Vol. 264, 3. P. 652656.

396. Interaction of glucocorticoids with macrophages.

Indentification of glucocorticoid receptors in monocytes and macrophages / Z. Werb, R. Foley, A. Munck et al. // J. Exp Med. 1978.

Vol. 147. P. 16841694.

397. Interactions among CNS, neuroendocrine and immune systems / R.M.A. Landmann, M. Wesp, R. Box. Rome: Pythagora Press, 1989.

P. 251264.

398. Intracerebroventricular but not intravenous interleukin1b induces widespread vascularmediated leukocyte infiltration and immune signal mRNA expression followed by brainwide glial activation / M.G. Proescholdt, S. Chakravarty, J. A. Foster et al. // Neuroscience. 2002. Vol. 112, 3. . 731749.

399. Intrathecal adenosine analog administration reduces substance P in cerebrospinal fluid along with behavioral effects that suggest antinociception in rats / K.F. Sjolund, A. Sollevi, M. Segerdahl, T.

Lundeberg // Anesth Analg. 1997. Vol. 85, 3. P. 627632.

400. Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients / G. Izquierdo, S. Angulo, J.M. GarciaMoreno et al. // Acta Neurologica Scandinavica. 2002. Vol. 105, 3. . 158163.

401. Investigation of cytokine (tumor necrosis factoralpha, interleukin6, interleukin10) concentrations in the cerebrospinal fluid of female patients with multiple sclerosis and systemic lupus erythematosus / K. Baraczka, K. Nekam, T. Pozsonyi et al. // European Journal of Neurology. 2004. Vol. 11, 1. . 3742.

402. Johnston M. Possible role of the cavernous sinus veins in cerebrospinal fluid absorption / M. Johnston, D. Armstrong, L. Koh // Cerebrospinal fluid research. 2007. Vol. 4, 3. P. 1 5.

403. Joseph S. Releasing hormones, LRF and TRF in the cerebrospinal fluid of the third ventricle / Joseph S., Sorrentino S., Sundberg D. // BrainEndocrine Interaction. II. The ventricular system.

2nd internat. sympos. Shizuoka, 1974, Basel, 1975. P. 306312.

404. Kabayashi H. Absorption of cerebrospinal fluid by ependimal cells of the median eminence / Kabayashi H. // BrainEndocrine Interaction. II. The ventricular system. 2nd internat. sympos. Shizuoka, 1974, Basel, 1975. P. 109122.

405. Kalin N.H. Cerebrospinal fluid corticotropinreleasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament / Kalin N.H., S.. Shelton, Davidson R.J. // Biol. Psychiatry. 2000. Vol. 47, 7. P. 579585.

406. Kamberi J.A. Effecys of melatonin and serotonin on the release of FSH and prolactin / Kamberi J.A., Mical R.S., Porter J. // Endocrinology. 1971. Vol. 88, 6. P. 12881293.

407. Karplus J. Ueber die Beeinflussung der Hypophysentatigkeit durch die Erregung des Hypothalamus / Karplus J., . Peczenik // Pflugers Arch. 1930. Bd. 225. S. 654668.

408. Kauers U. The diagnostic validity of lysozyme activity in lumbal Cerebrospinal fluid and in serum / Kauers U., . Weisner // J.

Clin. and Clin. Biochem. 1981. Vol. 19, 8. P. 726727.

178 409. Kendall J. Etudes on the transport of hormones from the cerebrospinal fluid to hypothalamus and pituitary / Kendall J., Jacobs I., R. Kramer // BrainEndocrine Interaction., Basel, 1972. P. 342349.

410. Kirschfink M., Rother S. CSF-filtration a new therapeutical concept /// Anaesthesia, Pain, Intensive Care and Emergency Medicine, A. Gullo (eds). Milano, 1994. .577-586.

411. Kjellin T. Der gehal an Prolan in Liquor cerebrospinalis besonders bei eccentieller Hypertonie /. Kjellin, . Kylin . // Deutsches Archfur Klinische medicin. 1934. Vol. 176, 6. .

683689.

412. Kleine T.O. Molecular heterogeneity, detected by two electrophoretic micro procedures, of IgG in human cerebrospinal fluid (CSF) /.. Kleine, . Damm . // Analytical and Bioanalytical Chemistry. 2003. Vol. 375, 8. . 10001005.

413. Knowles F. Cerebrospinal fluid and endocrine regulation / Knowles F. // Proc. internat. Sympos. Bratislava, 1974. P. 1128.

414. Konagaya Y. Abnormality of hypothalamic dopaminergic system in neurodegenerative diseasesevaluation of alpha melanocytestimulating hormonelike immunoreactivity in Cerebrospinal fluid / Konagaya Y., . Konagaya // Rinsho Shinkeigaku.

1991. Vol. 31, 8. P. 821825.

415. Kontinuierliche liquorfiltration bei foudroyanter bakterieller meningitis / Kalischewski P., Berrouschot J., Kohn H.-J. et al. //Akta Neurol. 1996. Vol. 23. . 61.

416. Kordon C. Role of neurotransmitters in the secretion of pituitary gonadotropins and prolactin / . Kordon C. //Control of ovulation. London, 1978. P. 2128.

417. Kratochvil A. Correlations Between the cerebrospinal fluid surface tension value and 1. Concentration of total proteins 2. Number of cell elements / . Kratochvil, . Hrncir E. // Gen. Phisiol. And Biophis. 2002. Vol. 21, 1. P. 4753.

418. Krubitzer L. Nature versus nurture revisited: an old idea with a new twist / L. Krubitzer, D. M. Kahn // Prog Neurobiol. 2003. Vol.

70. P. 3352.

419. Kwon C.H. Pten regulates neuronal arborization and social interaction in mice / .. Kwon // Neuron. 2006. vol. 50. P. 377388.

420. Lack of correlation between cerebrospinal fluid thyrotropin releasing hormone (TRH) and TRHstimulated thyroidstimulating hormone in patients with depression / M.A. Frye, R.T. Dunn, K.A. Gary et al. // Biol Psychiatry. 1999. Vol. 45, 8. P. 10491052.

421. Landt M. Leptin in cerebrospinal Fluid from children:

correlation with plasma leptin, sexual dimorphism, and lack of protein binding / . Landt, Parvin C.A., . Wong M. // Clin. Chem. 2000. Vol. 46, 6. P. 854858.

422. Lefvert A.KIg G production with the central nervous system, a critical review of proposed formulae / .. Lefvert, Link H. // Ann.

neurol. 1984. Vol.16, 5. P. 1320.

423. Liquorpherese ein neuer ansatz in der therapie des Guillain Barre syndroms / Hulser P.J., Wollinsky K.H., Weindler M. et al. //Verh Dtsch Ges Neurol. 1990. Vol. 6. . 620-621.

424. Liquorpherese bei 10 patienten mit multipler skleros./ Wollinsky K.H., Hulser P.J., Mauch E. et al. // Verb Dtsch Ges Neurol.

1992. Vol. 7. . 444-445.

425. Liquor-pheresis (CSF-Filtration) an effective treatment in acute and chronic severe autoimmune polyradiculoneuritis (Guillain Barre syndrome)/ Wollinsky K.H., Weindler M., Hulser P.J. et al. // Eur Arch Psych Clin Neurosci. 1991. Vol. 241. . 73-76.


426. Liu Guoqing. Zhang Xiaorong. Zhao Youzhang // Zhongswo shouyi xuebao = Chin. J. Vet. Sci. 2002. Vol. 22. 3. . 265266.

427. Liu Z. A highrecovery extraction procedure for quantitative analysis of substance P and opioid peptides in human cerebrospinal fluid / Liu Z., . Welin, Bragee B. F. // Nyberg Peptides. 2000. Vol. 21, 6. P. 853860.

428. Low calcitonin generelated, peptidelike immunoreactivity in cerebrospinal fluid from chronic pain patients / C. Lindh, Z. Liu, M.

Welin et al. // Neuropeptides. 1999. Vol. 33, 6. P. 517521.

429. Luteinizing hormone (LH)releasing hormone in third ventricular cerebrospinal fluid of the ewe: correlation with LH pulses and the LH surge / D.C. Skinner, . Malpaux, . Delaleu, A. Caraty // Endocrinology. 1995. Vol. 136, 8. P. 32303237.

180 430. Lymphocyte blast transformation. Demonstration of adrenergic receptors in human peripheral lymphocytes / J.W. Hadden, E.M. Hadden, E.J. Middleton et al. // Cell Immunol. 1970. Vol. 1. P. 583595.

431. Lyson K. The effect of interleukin6 on pituitary hormone release in vivo and in vitro / . Lyson K., S.. McCann // Neuroendocrinology. 1991. Vol. 54. P. 262266.

432. Macrophages and neurodegeneration / J.J. Hendriks, C.E.

Teunissen, H.E. Vries et al. // Brain Res Brain Res Rev. 2005. Vol.

48. P. 185195.

433. Manfredi P.L. CSF filtration is an effective treatment of Guillain-Barre syndrome A randomized clinical trial / Manfredi P.L.

//Neurology. 2002. Vol 58. . 988989.

434. Marquette C. IL1 beta, TNF alpha and IL6 inductions in the rat brain after portalbody irradiation: role of vagal afferents / .

Marquette // Int. J. Radiat. Biol. 2003. Vol. 79, 10. P. 777785.

435. Martin S.B. Tumor necrosus factor a (TNF) in neuroimmunology / S.. Martin, Tracey K.J. // Adv Neuroimmunol. 1992. Vol. 2. P. 125138.

436. Martinez M. Changes cerebrospinal fluid cAMP levels in Alzheimer's disease patients / . Martinez // Brain Res. 1998. Vol.

834, 2. P. 223242.

437. Measuring HIV1 RNA and interferonalpha in the cerebrospinal fluid of AIDS patients: insights into the pathogenesis of AIDS Dementia Complex / A. Krivine, G. Force, J. Servan et al. // J.

Neurovirol. 1999. Vol. 5, 5. P. 500 506.

438. Melrose Patricia Ann. Anatomical and hormonal studies investigating a possible role for cerebrospinal fluid in neuroendocrine communication associated with the control of reproduction (horse) / Melrose Patricia Ann //Dissertation Abstracts International. 1984. Vol. 44, 6. P. 1742.

439. Mess B. Effects of intracerebral serotonin administration on the function of the thyrotrophic hormone (TSH) thyreoid system / .

Mess, Peter L. // Endocrinol. Exp. Vol. 8, 3. P. 160168.

440. Miyake A. Luteinizing hormonereleasing hormone in cerebrospinal fluid of women/ . Miyake, Kurachi ., Kawamurra J. // Endocr. Jap. 1980. Vol. 27, 1. P. 117119.

441. Modulation of inflammation and immunity by cyclic AMP Receptors for vasoactive hormones and mediators of inflammation regulate many leukocyte functions / H.R. Bourne, L.M. Lichtenstein, K.L. Melmon et al. // Science. 1974. Vol. 184. P. 1928.

442. Molecular mechanisms of cerebrospinal fluid production / P.

D. Brown, S. L. Davies, T. Speake et al. // Neuroscience. 2004. Vol.

129, 4. P. 957970.

443. Multiplicity of cerebrospinal fluid functions: new challenges in health and disease / C.E. Johanson, J.A. Duncan, P.M. Klinge et al. // Cerebrospinal fluid research. 2008. Vol. 5, 10. P. 1 32.

444. Nathanson J.A. Immunological function of the blood cerbrospinal fluid barrier / Nathanson J.A., Chun L.Y. // Proc. Natl.

Acad. Sci. USA. 1989. Vol. 86, 3. P. 16841688.

445. Negro M.F. Sur La fonction et Laktion du liquide cephalo nachidien / Negro M.F.// Revue Neurologigi. 1931. Vol. 11, 6. . 790794.

446. Nerenbery S.T. Cerebrospinal fluid Ig G, Ig A, Ig M, Ig D and Ig E. Levels in central nervous system disoders / S.. Nerenbery, R. Prasad, M.E. Kothman // Neurology. 1978. Vol.28, 10. P. 988990.

447. Neuroendocrine modulation of immune system / G. Dan, S.B.

Lall // Indian Journal of Pharmacology. 1998. Vol. 30. P.129140.

448. Neuropeptide Y and corticotropinreleasing hormone in CSF mark response to antidepressive treatment with citalopram / G. Nikisch, H. Agren, C.B. Eap et al. // The International Journal of Neuropsychopharmacology. 2005. Vol. 8, 3. P. 403410.

449. Ojeda S. Central effect of prostaglandin E1 (PGE1) on prolactin release / S. Ojeda, . Harnes, S. McConn // Endocrinology. 1974. Vol. 95, 2. P. 613 450. Ottaway C.A. Vasoactive intestinal peptide and immune function // Ottaway C.A. / Psychoneuroimmunology. 2 ed. New York: Academic Press Inc., 1991. P. 225262.

451. Pardridge W.M. The bloodbrain barrier: cellular and molecular biology/ Pardridge W.M.. New York: Raven Press, 1993. 430 p.

182 452. Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease / M.A. Raskind, E.R. Peskind, C. Holmes, D.S. Goldstein // Biol.

Psychiatry. 1999. Vol. 46, 6. P. 756765.

453. Pavel S. Presence of relative high concentrations of arginine vasotocin in the cerebrospinal fluid of newborns and infants / S. Pavel // J Clin. Endocr. 1980. Vol. 50, 2. P. 271273.

454. Peptide repertoire of human cerebrospinal uid: novel proteolytic fragments of neuroendocrine proteins / M. Stark, O.

Danielsson, W.J. Grifths et al. // Journal of Chromatography B. 2001.

Vol. 754. P. 357 367.

455. Permeability of the bloodcerebrospinal fluid barrier to plasma proteins during fetal and perinatal life / . Adinolfi, S.. Beck, S.A.

Haddad, M.H. Seller // Nature. 1976. Vol.259. P. 140.

456. Plasma and cerebrospinal fluid amino acids in epileptic patients / S. Rainesalo, T. Keranen, J. Palmio et al. // Neurochemical Research. 2004. Vol. 29, 1. . 319324.

457. Plasma and cerebrospinal fluid concentration of neuropeptide Y, serotonin, and catecholamines in patients under propofol or isoflurane anesthesia / E. Grouzmann, A. Borgeat, M. Fathi et al. // Can.

J. Physiol. Pharmacol. 2000. Vol. 78, 2. P. 100107.

458. Podell M. Cerebrospinal fluid gammaaminobutyric acid and glutamate values in patients with epilepsy / . Podell, Hadjiconstantinou . // Am. J. Vet. Res. 1997. Vol. 58, 5. P.

451456.

459. Porter J. Role of biogenic amines and cerebrospinal fluid in the neurovascular transmittal of hypophysotrophic substances / Porter J., Kamberi I., Ondo J. // BrainEndocrine Interaction. Basel, 1972. P.

245253.

460. Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica / H. Brisby, K. Olmarker, K.

Larsson et al. // European Spine Journal. 2002. Vol. 11, 1. .

6266.

461. Prolactin receptor on human lymphocytes and their modulation by cyclosporin / Russell D.H., Matrision L., R. Kibler R. et al. // Biochem Biophys Res Commun. 1984. Vol.121. P. 899906.

462. Proopiocortin peptides in rat Cerebrospinal fluid / S. Jackson, S. Kiser, R. Corder, P.J. Lowry // Regul Pept. 1985. Vol. 11, 2. P. 159171.

463. Puri C.P. Bioactive luteinizing hormone in the plasma and cerebrospinal fluid of female rhesus monkeys / .. Puri, Puri V., Anand Kumar .. // J. Med. Primatol. 1980. Vol. 9, 1 2. P. 3949.


464. Receptors for interleukin1 (alpha and beta) in mouse brain:

mapping and neuronal localization in hippocampus / E. Ban, G. Milon, N. Prudhomme et al. // Neuroscience. 1991. Vol. 43. P. 2130.

465. Richman D.P. Nicotinic acetylcholine receptor evidence for a functionally distinct receptor on human lymphocytes / D.P. Richman, B.G.

Arnason // Proc Natl Acad Sci USA. 1979. Vol. 76. P. 46324635.

466. Riikonen R. Levels of cerebrospinal fluid nervegrowth factor differ in infantile autism and Rett syndrome / R. Riikonen, R. Vanhala //Developmental Medicine and Child Neurology. 1999. Vol. 41, 3. P.148 152.

467. Rodriquez E. Morphological and functional relationships between the hypothalamoneurophisical system and cerebrospinal fluid / . Rodriquez // Aspects of neuroendocrinology. V. Internat. Sympos. on neurosecretion. (eds. W. Bargman, B. Scharrer). Berlin N.Y., 1970.

P. 352365.

468. Rosler N. Intra vital lumbar and post mortem ventricular cerebrospinal fluid immunoreactive interleukin6 in Alzheimer's disease patients / Rosler N., Wichart I., .. Jellinger // Acta Neurologica Scandinavica. 2001. Vol. 103, 2. P. 126130.

469. Rossi S. Rapid quantification of the dopioid receptor selective enkephalin DPDPE in canine cerebrospinal fluid by liquid chromatographymass spectrometry / S. Rossi, Yaksh T. // Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 2002. Vol. 772, 1. . 7379.

470. Rother S. Filtration of liquor cerebrospinalis (CSF-filtration) technical concept and filter performance under in vitro conditions / Rother S., Knoblauch K.D., Kirschfink M.. //Neuropsychology. 1995.

Vol. 9. . 82-85.

471. Sagen J. Adrenal Medullary Transplants Increase Spinal Cord Cerebrospinal Fluid Catecholamine Levels and Reduce Pain Sensitivity / 184 Sagen J., Kemmler J.E., . Wang // The Journal of Neurophysiology. 2001. Vol. 85, 4. . 1788-1792.

472. Samuel S. Compartmentation in amino acid transport across the blood brain barrier / S. Samuel, S. . Schwartz // Neurochem res. 1981. Vol.6. P. 755759.

473. Sass J.O. Normal ascorbic acid in cerebrospinal fluid of patients with infantile neuronal ceroidlipofuscinosis / Sass J.O., Skladal D., . BrunnerKrainz // Metab Brain Dis. 1999. Vol. 14, 1. P.

6770.

474. Scott D. The ventricular system in neuroendocrine mechanisms/ Scott D., Dudley G., . Knigge // Cell and Tissue res. 1974. Vol. 154, 1. P. 116.

475. Scott Th. F. Pattern and concentration of Ig G in cerebrospinal fluid in neurosarcoidosis / Scott Th. F., .R. Seay A.R., Goust G.M. // Neurol. 1989. Vol.39. P. 16371639.

476. Semenenia I.N. Changes in the prolactin content of the cerebrospinal fluid and blood serum in rabbits in dynamic hyperthermia induced by Freund's complete adjuvant / Semenenia I.N., Gurin A.V. // Zh Evol Biokhim Fiziol. 1998. Vol. 34, 2. P. 270272.

477. Serial CSF corticotropinreleasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder / D.G. Baker, S.A. West, W.E. Nicholson et al. // Am. J.

Psychiatry. 1999. Vol 156, 4. . 585588.

478. Serotonin in cisternal cerebrospinal fluid of rhesus monkeys:

basal levels and effects of sertraline administration / G.M. Anderson, A.J. Bennett, K.P. Weld et al. // Psychopharmacology. 2002. Vol.

161, 1. . 9599.

479. Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers / A. Rousseau, S. Petren, J.

Plannthin et al. // J. Neural. Transm. 1999. Vol. 106, 9 10. P.

883888.

480. Sharief M.K. Intrathecal synthesis of Ig M in neurological diseases: a comparison between detection of oligoclonal bands and quantitative estimation / .. Sharief, Keir G., Thompson E.J. // J.

Neurol. Sci. 1990. Vol. 96. P. 131142.

481. Shuller E. Central nervous system Ig G synthesis in multiple sclerosis. Application of a new formula / Shuller E., Sagar H.J. //Acta Neurol. Scand. 1983. Vol.67, 6. P. 365371.

482. Simultaneous assay of prostaglandins and thromboxane in the cerebrospinal fluid by gas chromatographymass spectrometryselected ion monitoring / . Obata, . Nagakura, H. Maeda et al. // J. Chromatogr.

. Biomed. Sci. Appl. 1999. Vol. 731, 1. P. 7381.

483. Skinner D.C. Does gonadotropinreleasing hormone in the cerebrospinal fluid modulate luteinizing hormone release / Skinner D.C., . Caraty A., Evans N.P. // Neuroendocrinology. 1998. Vol. 67, 1. P. 3744.

484. Speake T. Expression of aquaporin 1 and aquaporin 4 water channels in rat choroid plexus / T. Speake, L.J. Freeman, P.D. Brown // Biochimica et Biophysica Acta. 2003. Vol. 1609. P. 80 86.

485. Specific nonopiate receptor for beta endorphins / E. Hazum, K.J. Chang, P. Cuatrecasas // Science. 1979. Vol. 205. P. 1033 1035.

486. Spinalfluid lisozyme in the diagnosis of the central nervous system tumors / Newman I., . Cacatian, Josephson A.S., . Tsang A. // Lancet. 1974. P. 756.

487. Spontaneous central melatonin secretion and resorption kinetics of exogenous melatonin: a ventricular CSF study / O. M. Debus, A. Lerchl, H. W. Bothe et al. // Journal of Pineal Research. 2002. Vol. 33, 4. . 213217.

488. Sterba G. Cerbrospinal fluid and hormones / Sterba G. // Ependima and neurohormonal regulation: Proc. Internat. Symposium. Bratislava., 1974. P. 143173.

489. Streptococcal meningitis effect of CSF filtration on inflammation and neuronal damage / Schmidt H., Stuertz ., Trostdorf F. et al. //J Neurol. 1999. Vol. 246. . 10631068.

490. Stumpf W. Estrogenneurons and. estrogenneuron systems in the periventricular brain / Stumpf W. // Amer. J. Anat. 1970. Vol.

129, 2. P. 207218.

491. Substance P recognition by a subset of human T lymphocyte / D. Payan, D. Brewster, A. MissirianBastian et al. // J. Clin. Invest. 1984. Vol. 74. P. 15321539.

186 492. Suzuki T. Transient elevation of interleukin6 levels at the initial stage of meningitis in children /. Suzuki, . Ishiguro, . Shimbo // Clinical and Experimental Immunology. 2003. Vol. 131, 3. .

484489.

493. Tabira T. Multiple sclerosis cerebrospinal fluid / Tabira T., Webster H. de F., S. . Wray S.H. // Neurocem. 1976. Vol. 59, 1.

. 1386 1390.

494. Tesch M. Liquorfiltration beim Stiff Man Syndrom / Tabira T., Webster H. de F., S.. Wray S.H. //Neurol Rehabil. 1998.

4. . 80-82.

495. The impact of lumbar cerebrospinal fluid filtration on lumbar and ventricular CSF in pneumococcal meningitis / . Pfausler, Stadlbaur D., Herold M., Schmutzhard E. // Neurol Infect Epidemiol. 1997. Vol.2. . 173-175.

496. The involvement of the bloodbrain and the blood cerebrospinal fluid barriers in the distribution of leptin into and out of the rat brain / D. Kurrimbux, Z. Gaffen, C.L. Farrell et al. // Neuroscience. 2004. Vol. 123, 2. . 527536.

497. The peptides of the immimneuroendocrine system /.Aim //European J. Histochemistry. 1993. Vol. 7. P. 10 12.

498. The role of monoamines in the control of gonadotropin and prolactin secretion / S. McCann, . Kalra P., Donoso A., Bishop W. et al. // BrainEndocrine Interaction. Basel, 1972. P. 224235.

499. The some immunobiological properties of a cerebrospinal fluid: cytotoxic, cytolytic effects, use of a cerebrospinal fluid as a nutrient medium for the cultivation of cells and tissues / ..

Kriventsov, Tkach V.V. (jr.), Bessalova Ye.Yu., Kiselev V.V. // - (English Edition). 2007. . 10, 3. . 257-259.

500. The syntax of immuneneuroendocrine communication / J.E.

Blalock // Immunol Today. 1994. Vol. 15. P. 504 511.

501. Thompson E. Proteins of cerebrospinal fluid / E. Thompson. Elsevier academic press, 2005. 332 c.

502. Tortella F.C. Characterization of opioid peptide like anticonvulsant activity in rat cerebrospinal fluid / Tortella F.C., Long J.B. // Brain Res. 1988. Vol. 456, 1. P. 139146.

503. Tortella F.C. Endogenous anticonvulsant substance in cerebrospinal fluid in rats after generalized seizures / Tortella F.C., Long J.B. // Brain Res. 1988. Vol. 456, 1. P. 439441.

504. Torzewski M. Integrated cytology of cerebrospinal fluid / M.

Torzewski, K.J. Lackner, J. Bohl. SpringerVerlag Berlin Heidelberg, 2008. 93 p.

505. Unger H. The vasopressin and oxytocin content in the cerebrospinal fluid of rabbits under changed conditions / . Unger, Schwarzberg H., Schulz H // Ependima and neurohormonal regulation:

Proc. Internat. Symposium. Bratislava., 1974. P. 251260.

506. Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study / M.P. Van den Berg, P. Merkus, S.G. Romeijn et al. // Pharmaceutical Research. 2004. Vol. 21, 5. . 799802.

507. Urwin S.C., Hunt P. Cerebrospinal fluid filtration in Guillain Barre syndrome / Urwin S.C., Hunt P. //Anaesthesia. 2000. Vol. 55, 5. . 503-504.

508. Van Duke H.B. Studying of cerebrospinal fluid / .. Van Duke, Balley ., Bucy .. // Pharmakol. and Experim Therap. 1929.

Vol. 36. P. 595610.

509. Vanhala R. Low levels of insulinlike growth factorI in cerebrospinal fluid in children with autism / R. Vanhala, U. Turpeinen, R. Riikonen // Developmental Medicine and Child Neurology. 2001. Vol. 43, 9. P.614 616.

510. Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus / P.

Koehne, F. Hochhaus, U. FelderhoffMueser et al. // Child's Nervous System. 2002. Vol. 18, 34. . 137141.

511. Vascular endothelial growth factor in the cerebrospinal fluid of infants who died of sudden infant death syndrome: Evidence for antecedent hypoxia / J.L. Kimberly, H.F. Krous, J. Nadeau, B.

Blackbourne // Pediatrics. 2003. Vol. 111, 2. . 358.

512. Wenkel H. Systemic immune deviation in the brain that does not depend on the integrity of the bloodbrain barrier / H. Wenkel, J.W.

Streilein, M.J. Young // The Journal of Immunology. 2000. Vol. 164.

P. 51255131.

188 513. Wieser H.G. Rasmussens encephalitis new treatment strategies / Wieser H.G. // The Third YONSEI Epilepsy Symposium. Seoul, 1996.

514. Wildt L. Hypothalamus. Reproductionsmedizin / Wildt L. // Ed Hrsg. Von Bettendorf G, Breckwoldt M. Stuttgart: Fischer,1989. P. 622.

515. Woo A.H.T. Brainimmune system interactions: analysis of immunoglobulin A in cerebrospinal fluid / A.H.T. Woo //Dissertation Abstracts International. 1992. Vol. 52, 9. P. 4662.

516. Wybran J. Interrelations between the immune system and the central nervous system: physiological, and pathological consequences / Wybran J. // Acta Clin. Belg. 1984. Vol. 39, 3. P. 131135.

517. Wybran J. Neuroimmunoendocrinology / Wybran J. // Immunology today. 1989. Vol. 10, 9. P. 319325.

518. Zhao W.G. erebrospinal fluid Ig G, Ig A, Ig m, Ig D and Ig E levels in healthy individuals with related parameters analysis / Zhao W.G.,Yu Y.C., Li Y.D. // J. Neuroimmunol. 1987. Vol.16, 1. P.

194.

519. Zubrzycka M. Substance P content in the cerebrospinal fluid and fluid perfusing cerebral ventricles during elicitation and inhibition of trigeminohypoglossal reflex in rats / Zubrzycka M., Janecka . // Brain Research. 2002. Vo l. 941, 12. . 2933.

................................... ............................................................................................. 1. ............................................................................................ 1.1 , .......................................................................................... 1.2 , , ............ 1.3 , ... 1.4 ................................... 1.5 , , ..... 1.6 ........................................................ 1.7 .................................................................. 1.8 , - ................... 2. ....................................................................................... 2.1 , , , .................................................. 2.2 , , , 充 2.3 酅. 2.4 : 腅. Ņ ….. Ņ 192 .. , .. , .. (.), .. , .. , .. в˻ 3562 28.08.2009 .

' , .

97513, , ѳ -, . , . ., . . (0652) 70-63-31, 050-648-89- e-mail:braznikov@mail.ru ϳ - 09.09.2010 .

60841/16. Times New Roman.

. . . 12,0. 300 .

. 402. ֳ .

³ ..

. ѳ, . , 21. . 105.

. (0652) 70-63-31, 050-648-89-34.

-mail: braznikov@mail.ru

Pages:     | 1 |   ...   | 3 | 4 ||
 
 >>  ()





 
<<     |    
2013 www.libed.ru - -

, .
, , , , 1-2 .